2 August 2013
Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.
In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths announces global, all employee share award as part of 175 year celebrations
Read our latest company news Smiths announces global, all employee share award as part of 175 year celebrations.
Find out more
Annual Results for the year ended 31 July 2026
Find out more
Smiths appoints new independent Non-executive Directors
Read our latest company news as the Board of Smiths is pleased to announce the appointments of Val Rahmani and Emma FitzGerald as independent Non-executive Directors.
Find out more
